Global Drug Repositioning Service Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Drug Repositioning Service market size is projected to grow from US$ 25700 million in 2022 to US$ 35860 million in 2029; it is expected to grow at a CAGR of 4.9% from 2023 to 2029.
Global Drug Repositioning key players include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, etc. Global top five manufacturers hold a share about 15%.
North America is the largest market, with a share about 40%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Generic Drugs is the largest segment, with a share about 65%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Diseases.
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
LPI (LP Information)' newest research report, the “Drug Repositioning Service Industry Forecast” looks at past sales and reviews total world Drug Repositioning Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Repositioning Service sales for 2023 through 2029. With Drug Repositioning Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Repositioning Service industry.
This Insight Report provides a comprehensive analysis of the global Drug Repositioning Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Repositioning Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Repositioning Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Repositioning Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Repositioning Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Repositioning Service market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Drug Repositioning Service market size is projected to grow from US$ 25700 million in 2022 to US$ 35860 million in 2029; it is expected to grow at a CAGR of 4.9% from 2023 to 2029.
Global Drug Repositioning key players include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, etc. Global top five manufacturers hold a share about 15%.
North America is the largest market, with a share about 40%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Generic Drugs is the largest segment, with a share about 65%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Diseases.
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
LPI (LP Information)' newest research report, the “Drug Repositioning Service Industry Forecast” looks at past sales and reviews total world Drug Repositioning Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Repositioning Service sales for 2023 through 2029. With Drug Repositioning Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Repositioning Service industry.
This Insight Report provides a comprehensive analysis of the global Drug Repositioning Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Repositioning Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Repositioning Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Repositioning Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Repositioning Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Repositioning Service market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Generic Drugs
- Clinical Trial Failed Drugs
- Cardiovascular Diseases
- Mental Illness
- Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biovista
- Anaxomics Biotech
- Segue Therapeutics
- GVK Biosciences
- LTT Bio-Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Repositioning Service Market Size 2018-2029
2.1.2 Drug Repositioning Service Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drug Repositioning Service Segment by Type
2.2.1 Generic Drugs
2.2.2 Clinical Trial Failed Drugs
2.3 Drug Repositioning Service Market Size by Type
2.3.1 Drug Repositioning Service Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drug Repositioning Service Market Size Market Share by Type (2018-2023)
2.4 Drug Repositioning Service Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Mental Illness
2.4.3 Cancer
2.4.4 Other
2.5 Drug Repositioning Service Market Size by Application
2.5.1 Drug Repositioning Service Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drug Repositioning Service Market Size Market Share by Application (2018-2023)
3 DRUG REPOSITIONING SERVICE MARKET SIZE BY PLAYER
3.1 Drug Repositioning Service Market Size Market Share by Players
3.1.1 Global Drug Repositioning Service Revenue by Players (2018-2023)
3.1.2 Global Drug Repositioning Service Revenue Market Share by Players (2018-2023)
3.2 Global Drug Repositioning Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUG REPOSITIONING SERVICE BY REGIONS
4.1 Drug Repositioning Service Market Size by Regions (2018-2023)
4.2 Americas Drug Repositioning Service Market Size Growth (2018-2023)
4.3 APAC Drug Repositioning Service Market Size Growth (2018-2023)
4.4 Europe Drug Repositioning Service Market Size Growth (2018-2023)
4.5 Middle East & Africa Drug Repositioning Service Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Drug Repositioning Service Market Size by Country (2018-2023)
5.2 Americas Drug Repositioning Service Market Size by Type (2018-2023)
5.3 Americas Drug Repositioning Service Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Repositioning Service Market Size by Region (2018-2023)
6.2 APAC Drug Repositioning Service Market Size by Type (2018-2023)
6.3 APAC Drug Repositioning Service Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drug Repositioning Service by Country (2018-2023)
7.2 Europe Drug Repositioning Service Market Size by Type (2018-2023)
7.3 Europe Drug Repositioning Service Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Repositioning Service by Region (2018-2023)
8.2 Middle East & Africa Drug Repositioning Service Market Size by Type (2018-2023)
8.3 Middle East & Africa Drug Repositioning Service Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUG REPOSITIONING SERVICE MARKET FORECAST
10.1 Global Drug Repositioning Service Forecast by Regions (2024-2029)
10.1.1 Global Drug Repositioning Service Forecast by Regions (2024-2029)
10.1.2 Americas Drug Repositioning Service Forecast
10.1.3 APAC Drug Repositioning Service Forecast
10.1.4 Europe Drug Repositioning Service Forecast
10.1.5 Middle East & Africa Drug Repositioning Service Forecast
10.2 Americas Drug Repositioning Service Forecast by Country (2024-2029)
10.2.1 United States Drug Repositioning Service Market Forecast
10.2.2 Canada Drug Repositioning Service Market Forecast
10.2.3 Mexico Drug Repositioning Service Market Forecast
10.2.4 Brazil Drug Repositioning Service Market Forecast
10.3 APAC Drug Repositioning Service Forecast by Region (2024-2029)
10.3.1 China Drug Repositioning Service Market Forecast
10.3.2 Japan Drug Repositioning Service Market Forecast
10.3.3 Korea Drug Repositioning Service Market Forecast
10.3.4 Southeast Asia Drug Repositioning Service Market Forecast
10.3.5 India Drug Repositioning Service Market Forecast
10.3.6 Australia Drug Repositioning Service Market Forecast
10.4 Europe Drug Repositioning Service Forecast by Country (2024-2029)
10.4.1 Germany Drug Repositioning Service Market Forecast
10.4.2 France Drug Repositioning Service Market Forecast
10.4.3 UK Drug Repositioning Service Market Forecast
10.4.4 Italy Drug Repositioning Service Market Forecast
10.4.5 Russia Drug Repositioning Service Market Forecast
10.5 Middle East & Africa Drug Repositioning Service Forecast by Region (2024-2029)
10.5.1 Egypt Drug Repositioning Service Market Forecast
10.5.2 South Africa Drug Repositioning Service Market Forecast
10.5.3 Israel Drug Repositioning Service Market Forecast
10.5.4 Turkey Drug Repositioning Service Market Forecast
10.5.5 GCC Countries Drug Repositioning Service Market Forecast
10.6 Global Drug Repositioning Service Forecast by Type (2024-2029)
10.7 Global Drug Repositioning Service Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biovista
11.1.1 Biovista Company Information
11.1.2 Biovista Drug Repositioning Service Product Offered
11.1.3 Biovista Drug Repositioning Service Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biovista Main Business Overview
11.1.5 Biovista Latest Developments
11.2 Anaxomics Biotech
11.2.1 Anaxomics Biotech Company Information
11.2.2 Anaxomics Biotech Drug Repositioning Service Product Offered
11.2.3 Anaxomics Biotech Drug Repositioning Service Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Anaxomics Biotech Main Business Overview
11.2.5 Anaxomics Biotech Latest Developments
11.3 Segue Therapeutics
11.3.1 Segue Therapeutics Company Information
11.3.2 Segue Therapeutics Drug Repositioning Service Product Offered
11.3.3 Segue Therapeutics Drug Repositioning Service Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Segue Therapeutics Main Business Overview
11.3.5 Segue Therapeutics Latest Developments
11.4 GVK Biosciences
11.4.1 GVK Biosciences Company Information
11.4.2 GVK Biosciences Drug Repositioning Service Product Offered
11.4.3 GVK Biosciences Drug Repositioning Service Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 GVK Biosciences Main Business Overview
11.4.5 GVK Biosciences Latest Developments
11.5 LTT Bio-Pharma
11.5.1 LTT Bio-Pharma Company Information
11.5.2 LTT Bio-Pharma Drug Repositioning Service Product Offered
11.5.3 LTT Bio-Pharma Drug Repositioning Service Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 LTT Bio-Pharma Main Business Overview
11.5.5 LTT Bio-Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Repositioning Service Market Size 2018-2029
2.1.2 Drug Repositioning Service Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drug Repositioning Service Segment by Type
2.2.1 Generic Drugs
2.2.2 Clinical Trial Failed Drugs
2.3 Drug Repositioning Service Market Size by Type
2.3.1 Drug Repositioning Service Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drug Repositioning Service Market Size Market Share by Type (2018-2023)
2.4 Drug Repositioning Service Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Mental Illness
2.4.3 Cancer
2.4.4 Other
2.5 Drug Repositioning Service Market Size by Application
2.5.1 Drug Repositioning Service Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drug Repositioning Service Market Size Market Share by Application (2018-2023)
3 DRUG REPOSITIONING SERVICE MARKET SIZE BY PLAYER
3.1 Drug Repositioning Service Market Size Market Share by Players
3.1.1 Global Drug Repositioning Service Revenue by Players (2018-2023)
3.1.2 Global Drug Repositioning Service Revenue Market Share by Players (2018-2023)
3.2 Global Drug Repositioning Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUG REPOSITIONING SERVICE BY REGIONS
4.1 Drug Repositioning Service Market Size by Regions (2018-2023)
4.2 Americas Drug Repositioning Service Market Size Growth (2018-2023)
4.3 APAC Drug Repositioning Service Market Size Growth (2018-2023)
4.4 Europe Drug Repositioning Service Market Size Growth (2018-2023)
4.5 Middle East & Africa Drug Repositioning Service Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Drug Repositioning Service Market Size by Country (2018-2023)
5.2 Americas Drug Repositioning Service Market Size by Type (2018-2023)
5.3 Americas Drug Repositioning Service Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Repositioning Service Market Size by Region (2018-2023)
6.2 APAC Drug Repositioning Service Market Size by Type (2018-2023)
6.3 APAC Drug Repositioning Service Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drug Repositioning Service by Country (2018-2023)
7.2 Europe Drug Repositioning Service Market Size by Type (2018-2023)
7.3 Europe Drug Repositioning Service Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Repositioning Service by Region (2018-2023)
8.2 Middle East & Africa Drug Repositioning Service Market Size by Type (2018-2023)
8.3 Middle East & Africa Drug Repositioning Service Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUG REPOSITIONING SERVICE MARKET FORECAST
10.1 Global Drug Repositioning Service Forecast by Regions (2024-2029)
10.1.1 Global Drug Repositioning Service Forecast by Regions (2024-2029)
10.1.2 Americas Drug Repositioning Service Forecast
10.1.3 APAC Drug Repositioning Service Forecast
10.1.4 Europe Drug Repositioning Service Forecast
10.1.5 Middle East & Africa Drug Repositioning Service Forecast
10.2 Americas Drug Repositioning Service Forecast by Country (2024-2029)
10.2.1 United States Drug Repositioning Service Market Forecast
10.2.2 Canada Drug Repositioning Service Market Forecast
10.2.3 Mexico Drug Repositioning Service Market Forecast
10.2.4 Brazil Drug Repositioning Service Market Forecast
10.3 APAC Drug Repositioning Service Forecast by Region (2024-2029)
10.3.1 China Drug Repositioning Service Market Forecast
10.3.2 Japan Drug Repositioning Service Market Forecast
10.3.3 Korea Drug Repositioning Service Market Forecast
10.3.4 Southeast Asia Drug Repositioning Service Market Forecast
10.3.5 India Drug Repositioning Service Market Forecast
10.3.6 Australia Drug Repositioning Service Market Forecast
10.4 Europe Drug Repositioning Service Forecast by Country (2024-2029)
10.4.1 Germany Drug Repositioning Service Market Forecast
10.4.2 France Drug Repositioning Service Market Forecast
10.4.3 UK Drug Repositioning Service Market Forecast
10.4.4 Italy Drug Repositioning Service Market Forecast
10.4.5 Russia Drug Repositioning Service Market Forecast
10.5 Middle East & Africa Drug Repositioning Service Forecast by Region (2024-2029)
10.5.1 Egypt Drug Repositioning Service Market Forecast
10.5.2 South Africa Drug Repositioning Service Market Forecast
10.5.3 Israel Drug Repositioning Service Market Forecast
10.5.4 Turkey Drug Repositioning Service Market Forecast
10.5.5 GCC Countries Drug Repositioning Service Market Forecast
10.6 Global Drug Repositioning Service Forecast by Type (2024-2029)
10.7 Global Drug Repositioning Service Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biovista
11.1.1 Biovista Company Information
11.1.2 Biovista Drug Repositioning Service Product Offered
11.1.3 Biovista Drug Repositioning Service Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biovista Main Business Overview
11.1.5 Biovista Latest Developments
11.2 Anaxomics Biotech
11.2.1 Anaxomics Biotech Company Information
11.2.2 Anaxomics Biotech Drug Repositioning Service Product Offered
11.2.3 Anaxomics Biotech Drug Repositioning Service Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Anaxomics Biotech Main Business Overview
11.2.5 Anaxomics Biotech Latest Developments
11.3 Segue Therapeutics
11.3.1 Segue Therapeutics Company Information
11.3.2 Segue Therapeutics Drug Repositioning Service Product Offered
11.3.3 Segue Therapeutics Drug Repositioning Service Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Segue Therapeutics Main Business Overview
11.3.5 Segue Therapeutics Latest Developments
11.4 GVK Biosciences
11.4.1 GVK Biosciences Company Information
11.4.2 GVK Biosciences Drug Repositioning Service Product Offered
11.4.3 GVK Biosciences Drug Repositioning Service Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 GVK Biosciences Main Business Overview
11.4.5 GVK Biosciences Latest Developments
11.5 LTT Bio-Pharma
11.5.1 LTT Bio-Pharma Company Information
11.5.2 LTT Bio-Pharma Drug Repositioning Service Product Offered
11.5.3 LTT Bio-Pharma Drug Repositioning Service Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 LTT Bio-Pharma Main Business Overview
11.5.5 LTT Bio-Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug Repositioning Service Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Generic Drugs
Table 3. Major Players of Clinical Trial Failed Drugs
Table 4. Drug Repositioning Service Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Drug Repositioning Service Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Table 7. Drug Repositioning Service Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Drug Repositioning Service Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Table 10. Global Drug Repositioning Service Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Drug Repositioning Service Revenue Market Share by Player (2018-2023)
Table 12. Drug Repositioning Service Key Players Head office and Products Offered
Table 13. Drug Repositioning Service Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drug Repositioning Service Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Drug Repositioning Service Market Size Market Share by Regions (2018-2023)
Table 18. Global Drug Repositioning Service Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Drug Repositioning Service Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Drug Repositioning Service Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Drug Repositioning Service Market Size Market Share by Country (2018-2023)
Table 22. Americas Drug Repositioning Service Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Table 24. Americas Drug Repositioning Service Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Table 26. APAC Drug Repositioning Service Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Drug Repositioning Service Market Size Market Share by Region (2018-2023)
Table 28. APAC Drug Repositioning Service Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Table 30. APAC Drug Repositioning Service Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Table 32. Europe Drug Repositioning Service Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Drug Repositioning Service Market Size Market Share by Country (2018-2023)
Table 34. Europe Drug Repositioning Service Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Table 36. Europe Drug Repositioning Service Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Drug Repositioning Service Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Drug Repositioning Service Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Drug Repositioning Service Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Drug Repositioning Service Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Drug Repositioning Service
Table 45. Key Market Challenges & Risks of Drug Repositioning Service
Table 46. Key Industry Trends of Drug Repositioning Service
Table 47. Global Drug Repositioning Service Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Drug Repositioning Service Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Drug Repositioning Service Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Drug Repositioning Service Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biovista Details, Company Type, Drug Repositioning Service Area Served and Its Competitors
Table 52. Biovista Drug Repositioning Service Product Offered
Table 53. Biovista Drug Repositioning Service Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biovista Main Business
Table 55. Biovista Latest Developments
Table 56. Anaxomics Biotech Details, Company Type, Drug Repositioning Service Area Served and Its Competitors
Table 57. Anaxomics Biotech Drug Repositioning Service Product Offered
Table 58. Anaxomics Biotech Main Business
Table 59. Anaxomics Biotech Drug Repositioning Service Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Anaxomics Biotech Latest Developments
Table 61. Segue Therapeutics Details, Company Type, Drug Repositioning Service Area Served and Its Competitors
Table 62. Segue Therapeutics Drug Repositioning Service Product Offered
Table 63. Segue Therapeutics Main Business
Table 64. Segue Therapeutics Drug Repositioning Service Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Segue Therapeutics Latest Developments
Table 66. GVK Biosciences Details, Company Type, Drug Repositioning Service Area Served and Its Competitors
Table 67. GVK Biosciences Drug Repositioning Service Product Offered
Table 68. GVK Biosciences Main Business
Table 69. GVK Biosciences Drug Repositioning Service Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. GVK Biosciences Latest Developments
Table 71. LTT Bio-Pharma Details, Company Type, Drug Repositioning Service Area Served and Its Competitors
Table 72. LTT Bio-Pharma Drug Repositioning Service Product Offered
Table 73. LTT Bio-Pharma Main Business
Table 74. LTT Bio-Pharma Drug Repositioning Service Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. LTT Bio-Pharma Latest Developments
Table 1. Drug Repositioning Service Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Generic Drugs
Table 3. Major Players of Clinical Trial Failed Drugs
Table 4. Drug Repositioning Service Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Drug Repositioning Service Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Table 7. Drug Repositioning Service Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Drug Repositioning Service Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Table 10. Global Drug Repositioning Service Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Drug Repositioning Service Revenue Market Share by Player (2018-2023)
Table 12. Drug Repositioning Service Key Players Head office and Products Offered
Table 13. Drug Repositioning Service Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drug Repositioning Service Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Drug Repositioning Service Market Size Market Share by Regions (2018-2023)
Table 18. Global Drug Repositioning Service Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Drug Repositioning Service Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Drug Repositioning Service Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Drug Repositioning Service Market Size Market Share by Country (2018-2023)
Table 22. Americas Drug Repositioning Service Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Table 24. Americas Drug Repositioning Service Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Table 26. APAC Drug Repositioning Service Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Drug Repositioning Service Market Size Market Share by Region (2018-2023)
Table 28. APAC Drug Repositioning Service Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Table 30. APAC Drug Repositioning Service Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Table 32. Europe Drug Repositioning Service Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Drug Repositioning Service Market Size Market Share by Country (2018-2023)
Table 34. Europe Drug Repositioning Service Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Table 36. Europe Drug Repositioning Service Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Drug Repositioning Service Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Drug Repositioning Service Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Drug Repositioning Service Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Drug Repositioning Service Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Drug Repositioning Service
Table 45. Key Market Challenges & Risks of Drug Repositioning Service
Table 46. Key Industry Trends of Drug Repositioning Service
Table 47. Global Drug Repositioning Service Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Drug Repositioning Service Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Drug Repositioning Service Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Drug Repositioning Service Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biovista Details, Company Type, Drug Repositioning Service Area Served and Its Competitors
Table 52. Biovista Drug Repositioning Service Product Offered
Table 53. Biovista Drug Repositioning Service Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biovista Main Business
Table 55. Biovista Latest Developments
Table 56. Anaxomics Biotech Details, Company Type, Drug Repositioning Service Area Served and Its Competitors
Table 57. Anaxomics Biotech Drug Repositioning Service Product Offered
Table 58. Anaxomics Biotech Main Business
Table 59. Anaxomics Biotech Drug Repositioning Service Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Anaxomics Biotech Latest Developments
Table 61. Segue Therapeutics Details, Company Type, Drug Repositioning Service Area Served and Its Competitors
Table 62. Segue Therapeutics Drug Repositioning Service Product Offered
Table 63. Segue Therapeutics Main Business
Table 64. Segue Therapeutics Drug Repositioning Service Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Segue Therapeutics Latest Developments
Table 66. GVK Biosciences Details, Company Type, Drug Repositioning Service Area Served and Its Competitors
Table 67. GVK Biosciences Drug Repositioning Service Product Offered
Table 68. GVK Biosciences Main Business
Table 69. GVK Biosciences Drug Repositioning Service Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. GVK Biosciences Latest Developments
Table 71. LTT Bio-Pharma Details, Company Type, Drug Repositioning Service Area Served and Its Competitors
Table 72. LTT Bio-Pharma Drug Repositioning Service Product Offered
Table 73. LTT Bio-Pharma Main Business
Table 74. LTT Bio-Pharma Drug Repositioning Service Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. LTT Bio-Pharma Latest Developments
LIST OF FIGURES
Figure 1. Drug Repositioning Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Repositioning Service Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Drug Repositioning Service Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Drug Repositioning Service Sales Market Share by Country/Region (2022)
Figure 8. Drug Repositioning Service Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Drug Repositioning Service Market Size Market Share by Type in 2022
Figure 10. Drug Repositioning Service in Cardiovascular Diseases
Figure 11. Global Drug Repositioning Service Market: Cardiovascular Diseases (2018-2023) & ($ Millions)
Figure 12. Drug Repositioning Service in Mental Illness
Figure 13. Global Drug Repositioning Service Market: Mental Illness (2018-2023) & ($ Millions)
Figure 14. Drug Repositioning Service in Cancer
Figure 15. Global Drug Repositioning Service Market: Cancer (2018-2023) & ($ Millions)
Figure 16. Drug Repositioning Service in Other
Figure 17. Global Drug Repositioning Service Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Drug Repositioning Service Market Size Market Share by Application in 2022
Figure 19. Global Drug Repositioning Service Revenue Market Share by Player in 2022
Figure 20. Global Drug Repositioning Service Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Drug Repositioning Service Market Size 2018-2023 ($ Millions)
Figure 22. APAC Drug Repositioning Service Market Size 2018-2023 ($ Millions)
Figure 23. Europe Drug Repositioning Service Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Drug Repositioning Service Market Size 2018-2023 ($ Millions)
Figure 25. Americas Drug Repositioning Service Value Market Share by Country in 2022
Figure 26. United States Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Drug Repositioning Service Market Size Market Share by Region in 2022
Figure 31. APAC Drug Repositioning Service Market Size Market Share by Type in 2022
Figure 32. APAC Drug Repositioning Service Market Size Market Share by Application in 2022
Figure 33. China Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Drug Repositioning Service Market Size Market Share by Country in 2022
Figure 40. Europe Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Figure 41. Europe Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Figure 42. Germany Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Drug Repositioning Service Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 56. APAC Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 57. Europe Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 59. United States Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 60. Canada Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 63. China Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 64. Japan Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 65. Korea Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 67. India Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 68. Australia Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 69. Germany Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 70. France Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 71. UK Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 72. Italy Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 73. Russia Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 74. Spain Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 77. Israel Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 80. Global Drug Repositioning Service Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Drug Repositioning Service Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Drug Repositioning Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Repositioning Service Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Drug Repositioning Service Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Drug Repositioning Service Sales Market Share by Country/Region (2022)
Figure 8. Drug Repositioning Service Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Drug Repositioning Service Market Size Market Share by Type in 2022
Figure 10. Drug Repositioning Service in Cardiovascular Diseases
Figure 11. Global Drug Repositioning Service Market: Cardiovascular Diseases (2018-2023) & ($ Millions)
Figure 12. Drug Repositioning Service in Mental Illness
Figure 13. Global Drug Repositioning Service Market: Mental Illness (2018-2023) & ($ Millions)
Figure 14. Drug Repositioning Service in Cancer
Figure 15. Global Drug Repositioning Service Market: Cancer (2018-2023) & ($ Millions)
Figure 16. Drug Repositioning Service in Other
Figure 17. Global Drug Repositioning Service Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Drug Repositioning Service Market Size Market Share by Application in 2022
Figure 19. Global Drug Repositioning Service Revenue Market Share by Player in 2022
Figure 20. Global Drug Repositioning Service Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Drug Repositioning Service Market Size 2018-2023 ($ Millions)
Figure 22. APAC Drug Repositioning Service Market Size 2018-2023 ($ Millions)
Figure 23. Europe Drug Repositioning Service Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Drug Repositioning Service Market Size 2018-2023 ($ Millions)
Figure 25. Americas Drug Repositioning Service Value Market Share by Country in 2022
Figure 26. United States Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Drug Repositioning Service Market Size Market Share by Region in 2022
Figure 31. APAC Drug Repositioning Service Market Size Market Share by Type in 2022
Figure 32. APAC Drug Repositioning Service Market Size Market Share by Application in 2022
Figure 33. China Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Drug Repositioning Service Market Size Market Share by Country in 2022
Figure 40. Europe Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Figure 41. Europe Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Figure 42. Germany Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Drug Repositioning Service Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Drug Repositioning Service Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Drug Repositioning Service Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Drug Repositioning Service Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 56. APAC Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 57. Europe Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 59. United States Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 60. Canada Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 63. China Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 64. Japan Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 65. Korea Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 67. India Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 68. Australia Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 69. Germany Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 70. France Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 71. UK Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 72. Italy Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 73. Russia Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 74. Spain Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 77. Israel Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Drug Repositioning Service Market Size 2024-2029 ($ Millions)
Figure 80. Global Drug Repositioning Service Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Drug Repositioning Service Market Size Market Share Forecast by Application (2024-2029)
